Report
EUR 12.91 For Business Accounts Only

With a more favourable environment, BUMRUNGRAD HOSPITAL improves to Positive

BUMRUNGRAD HOSPITAL (TH), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date March 29, 2022, the closing price was THB 158.50 and its potential was estimated at THB 176.71.
Underlying
Bumrungrad Hospital Public Co. Ltd.

Bumrungrad Hospital Public Company Limited is a Thailand-based company engaged in the provision of healthcare services in Bangkok, namely Bumrungrad hospital, which serves both local and international wards. The Company provides healthcare services for both outpatients and inpatients, including medical services, heart center, dental center, allergy center, and other related services. It also provides emergency care, full equipped operation theaters and an international patient service center to accommodate international patients. Its subsidiaries are including Vitallife Corporation Limited, Asia Global Health Limited, Asia Global Research Company Limited and Ruenmongkol Company Limited. On October 24, 2013, it established a new subsidiary, namely Life and Longevity Limited. On March 4, 2014, it established a new subsidiary, namely Health Horizons Enterprises Pte Ltd.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch